Discovery Labs Receives FDA Recommendations and Request for Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications
[at noodls] – Discovery Labs Receives FDA Recommendations and Request for Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications Warrington, PA – April 15, 2013 – Discovery … moreView todays social media effects on DSCOView the latest stocks trending across Twitter. Click to view dashboardSee who Discovery is hiring next, click here to view […]